Patrick M Forde

29PUBLICATIONS
299CO-AUTHORS
Cancer geneticsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 01, 2026
Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a Canonical <i>EGFR</i> Mutation: A Molecular Tumor Board Discussion.

|Apr 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer.

|Apr 19, 2026
plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

|Mar 18, 2026
How Much Is Enough? Ultra-Low Doses of Immunotherapy to Improve Access and Affordability.

M Raheel Khan, Patrick M Forde

|Sep 08, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses.

Joshua E Reuss, Paul K Lee, Reza J Mehran

|Jun 02, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.

Patrick M Forde, Jonathan D Spicer, Mariano Provencio

Pageof 5

Frequent Collaborators

16 joint publications

Valsamo Anagnostou

8 joint publications

Kellie N Smith

7 joint publications

Joseph Murray

6 joint publications

Jonathan Spicer